Global Bio-protein Drug Sales Market Report 2021

1 Bio-protein Drug Market Overview

• 1.1 Bio-protein Drug Product Scope
• 1.2 Bio-protein Drug Segment by Type
  • 1.2.1 Global Bio-protein Drug Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Therapeutic Proteins
  • 1.2.4 Vaccines
• 1.3 Bio-protein Drug Segment by Application
  • 1.3.1 Global Bio-protein Drug Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Pharma and Biotech Companies
  • 1.3.3 CROs
  • 1.3.4 Academics
• 1.4 Bio-protein Drug Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Bio-protein Drug Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Bio-protein Drug Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Bio-protein Drug Price Trends (2016-2027)

2 Bio-protein Drug Estimates and Forecasts by Region

• 2.1 Global Bio-protein Drug Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Bio-protein Drug Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Bio-protein Drug Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Bio-protein Drug Revenue Market Share by Region (2016-2021)
• 2.3 Global Bio-protein Drug Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Bio-protein Drug Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Bio-protein Drug Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Bio-protein Drug Estimates and Projections (2016-2027)
  • 2.4.2 Europe Bio-protein Drug Estimates and Projections (2016-2027)
  • 2.4.3 China Bio-protein Drug Estimates and Projections (2016-2027)
  • 2.4.4 Japan Bio-protein Drug Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Bio-protein Drug Estimates and Projections (2016-2027)
  • 2.4.6 India Bio-protein Drug Estimates and Projections (2016-2027)

3 Global Bio-protein Drug Competition Landscape by Players

• 3.1 Global Top Bio-protein Drug Players by Sales (2016-2021)
• 3.2 Global Top Bio-protein Drug Players by Revenue (2016-2021)
• 3.3 Global Bio-protein Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-protein Drug as of 2020)
• 3.4 Global Bio-protein Drug Average Price by Company (2016-2021)
• 3.5 Manufacturers Bio-protein Drug Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Bio-protein Drug Market Size by Type

• 4.1 Global Bio-protein Drug Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Bio-protein Drug Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Bio-protein Drug Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Bio-protein Drug Price by Type (2016-2021)
• 4.2 Global Bio-protein Drug Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Bio-protein Drug Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Bio-protein Drug Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Bio-protein Drug Price Forecast by Type (2022-2027)

5 Global Bio-protein Drug Market Size by Application

• 5.1 Global Bio-protein Drug Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Bio-protein Drug Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Bio-protein Drug Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Bio-protein Drug Price by Application (2016-2021)
• 5.2 Global Bio-protein Drug Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Bio-protein Drug Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Bio-protein Drug Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Bio-protein Drug Price Forecast by Application (2022-2027)

6 North America Bio-protein Drug Market Facts & Figures

• 6.1 North America Bio-protein Drug Sales by Company
  • 6.1.1 North America Bio-protein Drug Sales by Company (2016-2021)
  • 6.1.2 North America Bio-protein Drug Revenue by Company (2016-2021)
• 6.2 North America Bio-protein Drug Sales Breakdown by Type
  • 6.2.1 North America Bio-protein Drug Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Bio-protein Drug Sales Breakdown by Type (2022-2027)
• 6.3 North America Bio-protein Drug Sales Breakdown by Application
  • 6.3.1 North America Bio-protein Drug Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Bio-protein Drug Sales Breakdown by Application (2022-2027)

7 Europe Bio-protein Drug Market Facts & Figures

• 7.1 Europe Bio-protein Drug Sales by Company
  • 7.1.1 Europe Bio-protein Drug Sales by Company (2016-2021)
  • 7.1.2 Europe Bio-protein Drug Revenue by Company (2016-2021)
• 7.2 Europe Bio-protein Drug Sales Breakdown by Type
  • 7.2.1 Europe Bio-protein Drug Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Bio-protein Drug Sales Breakdown by Type (2022-2027)
• 7.3 Europe Bio-protein Drug Sales Breakdown by Application
  • 7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Bio-protein Drug Market Facts & Figures

• 8.1 China Bio-protein Drug Sales by Company
  • 8.1.1 China Bio-protein Drug Sales by Company (2016-2021)
  • 8.1.2 China Bio-protein Drug Revenue by Company (2016-2021)
• 8.2 China Bio-protein Drug Sales Breakdown by Type
  • 8.2.1 China Bio-protein Drug Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Bio-protein Drug Sales Breakdown by Type (2022-2027)
• 8.3 China Bio-protein Drug Sales Breakdown by Application
  • 8.3.1 China 165 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 165 Sales Breakdown by Application (2022-2027)

9 Japan Bio-protein Drug Market Facts & Figures

• 9.1 Japan Bio-protein Drug Sales by Company
  • 9.1.1 Japan Bio-protein Drug Sales by Company (2016-2021)
  • 9.1.2 Japan Bio-protein Drug Revenue by Company (2016-2021)
• 9.2 Japan Bio-protein Drug Sales Breakdown by Type
  • 9.2.1 Japan Bio-protein Drug Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Bio-protein Drug Sales Breakdown by Type (2022-2027)
• 9.3 Japan Bio-protein Drug Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Bio-protein Drug Market Facts & Figures

• 10.1 Southeast Asia Bio-protein Drug Sales by Company
  • 10.1.1 Southeast Asia Bio-protein Drug Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Bio-protein Drug Revenue by Company (2016-2021)
• 10.2 Southeast Asia Bio-protein Drug Sales Breakdown by Type
  • 10.2.1 Southeast Asia Bio-protein Drug Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Bio-protein Drug Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Bio-protein Drug Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Bio-protein Drug Market Facts & Figures

• 11.1 India Bio-protein Drug Sales by Company
  • 11.1.1 India Bio-protein Drug Sales by Company (2016-2021)
  • 11.1.2 India Bio-protein Drug Revenue by Company (2016-2021)
• 11.2 India Bio-protein Drug Sales Breakdown by Type
  • 11.2.1 India Bio-protein Drug Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Bio-protein Drug Sales Breakdown by Type (2022-2027)
• 11.3 India Bio-protein Drug Sales Breakdown by Application
  • 11.3.1 India Bio-protein Drug Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Bio-protein Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Bio-protein Drug Business

• 12.1 Abbott Laboratories
  • 12.1.1 Abbott Laboratories Corporation Information
  • 12.1.2 Abbott Laboratories Business Overview
  • 12.1.3 Abbott Laboratories Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Abbott Laboratories Bio-protein Drug Products Offered
  • 12.1.5 Abbott Laboratories Recent Development
• 12.2 Bayer AG
  • 12.2.1 Bayer AG Corporation Information
  • 12.2.2 Bayer AG Business Overview
  • 12.2.3 Bayer AG Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Bayer AG Bio-protein Drug Products Offered
  • 12.2.5 Bayer AG Recent Development
• 12.3 Eli Lilly and Company
  • 12.3.1 Eli Lilly and Company Corporation Information
  • 12.3.2 Eli Lilly and Company Business Overview
  • 12.3.3 Eli Lilly and Company Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Eli Lilly and Company Bio-protein Drug Products Offered
  • 12.3.5 Eli Lilly and Company Recent Development
• 12.4 Amgen Inc.
  • 12.4.1 Amgen Inc. Corporation Information
  • 12.4.2 Amgen Inc. Business Overview
  • 12.4.3 Amgen Inc. Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Amgen Inc. Bio-protein Drug Products Offered
  • 12.4.5 Amgen Inc. Recent Development
• 12.5 Biocon Ltd.
  • 12.5.1 Biocon Ltd. Corporation Information
  • 12.5.2 Biocon Ltd. Business Overview
  • 12.5.3 Biocon Ltd. Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Biocon Ltd. Bio-protein Drug Products Offered
  • 12.5.5 Biocon Ltd. Recent Development
• 12.6 Dr. Reddy’s Laboratories
  • 12.6.1 Dr. Reddy’s Laboratories Corporation Information
  • 12.6.2 Dr. Reddy’s Laboratories Business Overview
  • 12.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Dr. Reddy’s Laboratories Bio-protein Drug Products Offered
  • 12.6.5 Dr. Reddy’s Laboratories Recent Development
• 12.7 Roche
  • 12.7.1 Roche Corporation Information
  • 12.7.2 Roche Business Overview
  • 12.7.3 Roche Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Roche Bio-protein Drug Products Offered
  • 12.7.5 Roche Recent Development
• 12.8 Fresenius kabi
  • 12.8.1 Fresenius kabi Corporation Information
  • 12.8.2 Fresenius kabi Business Overview
  • 12.8.3 Fresenius kabi Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Fresenius kabi Bio-protein Drug Products Offered
  • 12.8.5 Fresenius kabi Recent Development
• 12.9 GlaxoSmithKline
  • 12.9.1 GlaxoSmithKline Corporation Information
  • 12.9.2 GlaxoSmithKline Business Overview
  • 12.9.3 GlaxoSmithKline Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 GlaxoSmithKline Bio-protein Drug Products Offered
  • 12.9.5 GlaxoSmithKline Recent Development
• 12.10 Johnson & Johnson
  • 12.10.1 Johnson & Johnson Corporation Information
  • 12.10.2 Johnson & Johnson Business Overview
  • 12.10.3 Johnson & Johnson Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Johnson & Johnson Bio-protein Drug Products Offered
  • 12.10.5 Johnson & Johnson Recent Development
• 12.11 Merck
  • 12.11.1 Merck Corporation Information
  • 12.11.2 Merck Business Overview
  • 12.11.3 Merck Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Merck Bio-protein Drug Products Offered
  • 12.11.5 Merck Recent Development
• 12.12 Novartis AG
  • 12.12.1 Novartis AG Corporation Information
  • 12.12.2 Novartis AG Business Overview
  • 12.12.3 Novartis AG Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Novartis AG Bio-protein Drug Products Offered
  • 12.12.5 Novartis AG Recent Development
• 12.13 Panacea Biotec
  • 12.13.1 Panacea Biotec Corporation Information
  • 12.13.2 Panacea Biotec Business Overview
  • 12.13.3 Panacea Biotec Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Panacea Biotec Bio-protein Drug Products Offered
  • 12.13.5 Panacea Biotec Recent Development
• 12.14 ProBioGen AG
  • 12.14.1 ProBioGen AG Corporation Information
  • 12.14.2 ProBioGen AG Business Overview
  • 12.14.3 ProBioGen AG Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 ProBioGen AG Bio-protein Drug Products Offered
  • 12.14.5 ProBioGen AG Recent Development
• 12.15 Sanofi
  • 12.15.1 Sanofi Corporation Information
  • 12.15.2 Sanofi Business Overview
  • 12.15.3 Sanofi Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Sanofi Bio-protein Drug Products Offered
  • 12.15.5 Sanofi Recent Development
• 12.16 Reliance Life Science Pvt. Ltd.
  • 12.16.1 Reliance Life Science Pvt. Ltd. Corporation Information
  • 12.16.2 Reliance Life Science Pvt. Ltd. Business Overview
  • 12.16.3 Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Reliance Life Science Pvt. Ltd. Bio-protein Drug Products Offered
  • 12.16.5 Reliance Life Science Pvt. Ltd. Recent Development

13 Bio-protein Drug Manufacturing Cost Analysis

• 13.1 Bio-protein Drug Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Bio-protein Drug
• 13.4 Bio-protein Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Bio-protein Drug Distributors List
• 14.3 Bio-protein Drug Customers

15 Market Dynamics

• 15.1 Bio-protein Drug Market Trends
• 15.2 Bio-protein Drug Drivers
• 15.3 Bio-protein Drug Market Challenges
• 15.4 Bio-protein Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List